Steven Slilaty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Steven slilaty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Steven Slilaty Today - Breaking & Trending Today

Lumen Technologies And 2 Other Stocks Under $2 Insiders Are Buying - Lumen Technologies (NYSE:LUMN), Nanophase Technologies (OTC:NANX)

The Dow Jones index closed higher by more than 100 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. ....

Bradfordt Whitmore , James Fowler , Steven Slilaty , Nanophase Technologies Corp , Sunshine Biopharma Inc , Nanophase Technologies Corporation , Dow Jones , Lumen Technologies Inc , Lumen Technologies , Lumen Technologies Does , United State , Nanophase Technologies Does , Goes Higher , Sunshine Biopharma , Sunshine Biopharma Does ,

Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033


Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033
March 11, 2021 09:00 ET
| Source:
Sunshine Biopharma Inc.
Sunshine Biopharma Inc.
Montreal, Quebec, CANADA
MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs today announced that it has received a “Notice of Allowance” from the European Patent Office for a new patent application covering Adva-27a, the Company’s flagship anticancer compound. This newly issued patent contains new subject matter and extends the proprietary protection of Adva-27a in Europe until 2033. The equivalent patent in the United States was issued in 2019 (US Patent Number 10,272,065) and similarly covers Adva-27a until 2033. The Canadian Intellectua ....

United States , Steven Slilaty , European Patent Office , Sunshine Biopharma Inc , Mcgill University Jewish , European Union , Canadian Intellectual Property , Sunshine Biopharma , Multidrug Resistant Cancer Cells , Pancreatic Cancer , Small Cell Lung Cancer , Breast Cancer , Uterine Sarcoma , Mcgill University , Jewish General Hospital , Otcbb Sbfm , Cancer Patent , Phamaceutical Research Center , Healthcare And Hospitals , ஒன்றுபட்டது மாநிலங்களில் , ஐரோப்பிய காப்புரிமை அலுவலகம் , மகில் பல்கலைக்கழகம் நகை , ஐரோப்பிய தொழிற்சங்கம் , கனடியன் அறிவுசார் ப்ராபர்டீ , கணையம் புற்றுநோய் , சிறிய செல் நுரையீரல் புற்றுநோய் ,